Quick Facts

• Cefixime is used in the management of specific bacterial infections affecting the respiratory and urinary tracts.
• Ofloxacin is utilized to address various bacterial infections, including those in the skin, urinary tract, and reproductive organs.
• The combination supports the treatment of susceptible infections in multiple organ systems.

---

Cefixime/ofloxacin is a combination medication indicated for the management of certain bacterial infections in adults and pediatric patients over six months of age. Cefixime is used to address infections of the urinary tract, pharyngitis and tonsillitis, acute exacerbations of chronic bronchitis, and uncomplicated gonorrhea. Ofloxacin is utilized in therapeutic regimens for various bacterial conditions, including uncomplicated and complicated urinary tract infections, certain skin and skin structure infections, and acute pelvic inflammatory disease.

Clinical guidelines recommend that this medication be utilized only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. Proper use is intended to maintain the effectiveness of this and other antibacterial drugs, supporting the resolution of the diagnosed condition. This approach aligns with established principles of antibiotic use.

Eligibility Map: Who can and cannot use Cefixime/Ofloxacin

The eligibility for this combination medicine is strictly defined by regulatory guidelines based on age, existing medical conditions, and known sensitivities.

Populations Not Eligible (Contraindications)

Category	Restriction
Hypersensitivity	Patients with a known allergy to Cefixime (cephalosporins) or Ofloxacin (fluoroquinolones).
Specific Disorders	Persons with myasthenia gravis or a history of tendon rupture/disorders related to prior fluoroquinolone use.
Reproductive Status	Often contraindicated or not recommended for pregnant and nursing mothers, primarily due to the Ofloxacin component.

---

Populations with Restricted or Conditional Use

Category	Official Restriction/Condition
Age	Safety and efficacy have not been established in infants less than six months of age. Ofloxacin is generally not recommended for growing adolescents.
Organ Function	Caution is required, and dosage adjustment is typically necessary, for patients with impaired renal (kidney) or hepatic (liver) function.
Comorbidities	Use requires caution in patients with a history of epilepsy, severe cerebral arteriosclerosis, or other CNS disorders.

The drug is generally approved for use in adults and pediatric patients six months of age or older for the Cefixime component, provided none of the contraindications are present.

Interactions with other medicines and products

This medication is subject to several clinically significant interaction patterns documented in official regulatory labeling.

Timing and Exposure Restrictions

Co-administration with multivalent cation-containing products, such as antacids and mineral supplements (e.g., iron, zinc, calcium), must be separated to prevent reduced absorption and systemic exposure of the Ofloxacin component. The regulatory labels mandate that Ofloxacin must be administered at least two hours before or two hours after these interacting substances. The concomitant use of high-dose Salicylates is documented to result in a 20–25% decrease in Cefixime plasma concentration.

Pharmacodynamic and Clearance Alterations

The combination requires close monitoring when used with Warfarin and other oral anticoagulants as both active agents may potentiate their effects, resulting in increased prothrombin time and bleeding risk. The use of the Ofloxacin component is generally contraindicated with Class IA and Class III Antiarrhythmic Agents due to an additive risk of QT interval prolongation. Co-administration with Probenecid is documented to increase Cefixime levels by decreasing its renal clearance. Elevated plasma levels of Carbamazepine have also been reported when co-administered with Cefixime. Official warnings also exist for the potential for hypoglycemia when Ofloxacin is combined with oral hypoglycemic agents.

Population Considerations

In patients with renal impairment, the risk of adverse effects from the Ofloxacin component is heightened due to reduced clearance and drug accumulation.

How Cefixime/Ofloxacin Works

The combination exerts a dual-mechanism bactericidal action by simultaneously targeting two essential life processes within susceptible bacteria.

---

Disrupting Structural Integrity

Cefixime targets Penicillin-Binding Proteins (PBPs), bacterial enzymes essential for constructing the cell wall. By irreversibly inhibiting these enzymes, Cefixime blocks the final step of peptidoglycan synthesis. This results in a structurally defective cell wall, leading to rapid bacterial swelling and subsequent osmotic lysis (rupture and death).

---

Disrupting Genetic Function

Ofloxacin targets bacterial Type II Topoisomerases (DNA Gyrase and Topoisomerase IV), enzymes necessary for managing DNA replication and separation. Ofloxacin stabilizes the DNA-enzyme complex, causing lethal double-strand DNA breaks and activating the bacterial SOS response. This irreversible genetic damage prevents the bacteria from multiplying and leads to programmed cell death.

---

Mechanism Synergy and Limitations

These two distinct mechanisms provide a synergistic effect, enhancing the bactericidal effect. This dual action contributes to the mitigation of resistance by targeting independent cellular pathways. However, the mechanism can be constrained by bacterial defense systems, such as efflux pumps actively removing the drugs, or mutations in the DNA Gyrase gene, which prevent Ofloxacin from binding to its target.

How to Use Cefixime/Ofloxacin — Official Administration Guidelines

The fixed-dose combination of Cefixime/Ofloxacin is administered via the oral route, typically using a tablet formulation, and is subject to precise instructions governing its intake, frequency, and duration.

Feature	Official Instruction
Route of administration	Oral route (ingestion).
Dosing schedule	One fixed-dose tablet (Cefixime 200 mg / Ofloxacin 200 mg) is generally prescribed for the standard adult regimen.
Timing in relation to meals	May be taken with or without food.
Preparation requirements	Tablets must be swallowed whole with sufficient liquid; do not crush or chew.
Special procedural conditions	The medication must not be taken within two hours of multivalent cation-containing products, such as antacids, sucralfate, iron, or zinc supplements, as these can interfere with the absorption of the Ofloxacin component.
Age-group administration rules	The combination is not recommended for use in children or growing adolescents. Geriatric patients do not typically require a dose change unless renal function is impaired.
Impaired organ function	Dose adjustment is required in adults whose creatinine clearance is less than 60 mL/min due to the clearance of both components.

---

Resulting Procedural Structure

The protocol requires the tablet to be taken twice daily at approximately equal intervals to maintain consistent drug levels. The duration of the treatment course typically ranges from 5 to 7 days, and treatment must not exceed 2 months due to the limitations associated with the fluoroquinolone component. The full prescribed course must be completed as directed by the prescribing authority.

Research Evidence / Overview of Studies

Scope of Investigation

Studies investigated the effect of the drug in relation to reported infections and inflammation. This combination formulation brings together cefixime, a third-generation cephalosporin antibiotic, and ofloxacin, a broad-spectrum fluoroquinolone antibiotic.

---

Clinical Trial Focus

Bacterial Infection Management

Clinical trials have evaluated the drug combination in the context of treating infections caused by susceptible bacteria, particularly those related to the respiratory and urinary tracts. Research focuses on whether the use of two agents is associated with different outcomes compared to monotherapy.

Dosage and Administration Protocols

Research protocols in acute infection trials often utilized an initial higher dose of the combination, followed by continued treatment at a standard lower dose. The rationale for specific dosing schedules is to maintain appropriate drug concentrations in the body necessary to affect bacterial processes.

Comparative Studies

Studies have assessed the drug's effects against those of other common antibiotic therapies. The primary endpoints in these trials centered on the measurement of changes in bacterial clearance rates and patient-reported measures of symptom resolution over the course of treatment.

---

Effects and Tolerability Profile

Clinical trials assessed the effects and tolerability of the drug following administration. Observed adverse events frequently reported across clinical trials included gastrointestinal discomfort and headache, which are common with antibiotic use. Due to the presence of ofloxacin, studies often pay close attention to potential tendon-related events and central nervous system effects.

Patients with known allergies to cephalosporins or quinolones, or those with a history of certain cardiovascular or central nervous system conditions, are typically assessed as a special population in clinical research.

Common questions about Cefixime/ofloxacin (FAQ)

Q: What is the primary use of the combination drug Cefixime/ofloxacin?

A: This combination medication, which contains the antibiotics Cefixime (a cephalosporin) and Ofloxacin (a fluoroquinolone), is primarily indicated for the treatment of certain bacterial infections. The specific infections addressed are generally determined by the prescribing healthcare provider based on the type of bacteria identified or suspected.

Q: How does the Cefixime component work to address bacterial infections?

A: Cefixime is classified as a third-generation cephalosporin antibiotic. It is a bactericidal agent, meaning it works by interfering with the development of the bacterial cell wall. This interference leads to the destruction of the bacterial cells.

Q: How does the Ofloxacin component work to address bacterial infections?

A: Ofloxacin is a broad-spectrum fluoroquinolone antibiotic. It works by inhibiting specific bacterial enzymes, DNA gyrase and topoisomerase IV, which are essential for bacterial DNA replication, repair, and transcription. By stopping these processes, Ofloxacin prevents the bacteria from multiplying.

Q: Is Cefixime/ofloxacin effective against viral infections, such as the common cold or flu?

A: No. Cefixime/ofloxacin, like all antibiotics, is specifically designed to target and inhibit the growth of bacteria. It is not effective against infections caused by viruses, such as the common cold, flu, or COVID-19. The medication should only be used to treat infections proven or strongly suspected to be caused by susceptible bacteria.

Q: What potential side effects are associated with the Cefixime/ofloxacin combination?

A: Like most medications, this combination may be associated with side effects. Commonly reported effects for the antibiotic classes involved include gastrointestinal disturbances (such as nausea, vomiting, or diarrhea) and headache. Due to the Ofloxacin component, there is also a known risk of adverse effects on the tendons (tendinitis or tendon rupture) and potential effects on the nervous system. Individuals who experience severe or persistent side effects should seek guidance from a healthcare professional.

Q: What is the general consensus regarding the use of alcohol while taking Cefixime/ofloxacin?

A: It is generally advised to avoid or limit the consumption of alcohol while taking this medication. Alcohol may potentially increase the severity of certain side effects, particularly nausea, dizziness, or headache. Always consult the prescribing healthcare provider for specific advice regarding alcohol intake during treatment.

Q: Can Cefixime/ofloxacin be taken during pregnancy or while breastfeeding?

A: The use of Cefixime/ofloxacin during pregnancy is typically not recommended unless the potential benefit justifies the potential risk, as determined by a healthcare provider. The components may pass into breast milk, which could potentially affect a nursing infant. A healthcare provider must evaluate the individual risks and benefits before recommending this medication during pregnancy or breastfeeding.

How to Store and Dispose of Cefixime/ofloxacin?

This medication should be stored in a tightly closed container at room temperature, away from excessive heat, moisture, and direct light. It is crucial to keep the product in a cool, dry place. Do not store this medicine in a bathroom environment.

Keep Cefixime/ofloxacin, along with all medications, out of the sight and reach of children and pets. This helps prevent accidental ingestion.

Disposal of Unused Medication:

To dispose of unused or expired Cefixime/ofloxacin, do not flush the tablets or suspension down the toilet or pour them into a drain. This can contaminate water supplies. The most recommended method is to use a community drug take-back program. If a take-back program is unavailable, consult your pharmacist or local waste disposal agency for instructions on safe home disposal.